The development of China's biopharmaceutical industry lags behind some western developed countries, but with the development of biotechnology, the gap between China and some foreign developed countries in the level of medicine is becoming smaller and smaller, and Biopharmaceutics has occupied a core position in the pharmaceutical field.

The biopharmaceutical industry chain, represented by monoclonal antibody drugs, including nucleic acid vaccines, blood products, recombinant protein drugs, peptide drugs, and gene therapy, is taking shape.

At present, nucleic acid vaccines, hormone and peptide drugs independently developed in China have been put on the market, and more than a dozen genetic engineering drugs are also in clinical trials.